Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 433

1.

Distinct sets of genetic alterations in melanoma.

Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Bröcker EB, LeBoit PE, Pinkel D, Bastian BC.

N Engl J Med. 2005 Nov 17;353(20):2135-47.

2.

Somatic activation of KIT in distinct subtypes of melanoma.

Curtin JA, Busam K, Pinkel D, Bastian BC.

J Clin Oncol. 2006 Sep 10;24(26):4340-6. Epub 2006 Aug 14.

3.

BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs.

Wong CW, Fan YS, Chan TL, Chan AS, Ho LC, Ma TK, Yuen ST, Leung SY; Cancer Genome Project.

J Clin Pathol. 2005 Jun;58(6):640-4. Review.

4.

Determinants of BRAF mutations in primary melanomas.

Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, Ono T, Albertson DG, Pinkel D, Bastian BC.

J Natl Cancer Inst. 2003 Dec 17;95(24):1878-90.

5.

Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.

Lázár V, Ecsedi S, Vízkeleti L, Rákosy Z, Boross G, Szappanos B, Bégány A, Emri G, Adány R, Balázs M.

Melanoma Res. 2012 Jun;22(3):202-14. doi: 10.1097/CMR.0b013e328352dbc8.

PMID:
22456166
6.

Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma.

Lázár V, Ecsedi S, Szöllosi AG, Tóth R, Vízkeleti L, Rákosy Z, Bégány A, Adány R, Balázs M.

Mod Pathol. 2009 Oct;22(10):1367-78. doi: 10.1038/modpathol.2009.109. Epub 2009 Jul 24.

7.

GAB2 amplifications refine molecular classification of melanoma.

Chernoff KA, Bordone L, Horst B, Simon K, Twadell W, Lee K, Cohen JA, Wang S, Silvers DN, Brunner G, Celebi JT.

Clin Cancer Res. 2009 Jul 1;15(13):4288-91. doi: 10.1158/1078-0432.CCR-09-0280. Epub 2009 Jun 9.

8.

The role of CCND1 alterations during the progression of cutaneous malignant melanoma.

Vízkeleti L, Ecsedi S, Rákosy Z, Orosz A, Lázár V, Emri G, Koroknai V, Kiss T, Ádány R, Balázs M.

Tumour Biol. 2012 Dec;33(6):2189-99. doi: 10.1007/s13277-012-0480-6. Epub 2012 Sep 23.

PMID:
23001925
9.

Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma.

Lee DA, Cohen JA, Twaddell WS, Palacios G, Gill M, Levit E, Halperin AJ, Mones J, Busam KJ, Silvers DN, Celebi JT.

Cancer. 2006 Feb 15;106(4):907-13.

10.

[Molecular heterogeneity of malignant melanomas].

Glatz K.

Pathologe. 2007 Nov;28(6):474-8. German.

PMID:
17885757
11.

[Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].

Lázár V.

Magy Onkol. 2013 Jun;57(2):96-9. doi: MagyOnkol.2013.57.2.96. Epub 2013 May 20. Hungarian.

12.

KIT pathway alterations in mucosal melanomas of the vulva and other sites.

Omholt K, Grafström E, Kanter-Lewensohn L, Hansson J, Ragnarsson-Olding BK.

Clin Cancer Res. 2011 Jun 15;17(12):3933-42. doi: 10.1158/1078-0432.CCR-10-2917.

13.

The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites.

Deichmann M, Krahl D, Thome M, Wüst K, Hassanzadeh J, Helmke B.

Int J Oncol. 2006 Jul;29(1):139-45.

PMID:
16773193
14.

Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis.

Lee JH, Choi JW, Kim YS.

Br J Dermatol. 2011 Apr;164(4):776-84. doi: 10.1111/j.1365-2133.2010.10185.x. Epub 2011 Mar 21.

PMID:
21166657
15.

BRAF alterations are associated with complex mutational profiles in malignant melanoma.

Daniotti M, Oggionni M, Ranzani T, Vallacchi V, Campi V, Di Stasi D, Torre GD, Perrone F, Luoni C, Suardi S, Frattini M, Pilotti S, Anichini A, Tragni G, Parmiani G, Pierotti MA, Rodolfo M.

Oncogene. 2004 Aug 5;23(35):5968-77.

PMID:
15195137
16.

Absence of BRAF mutations in UV-protected mucosal melanomas.

Edwards RH, Ward MR, Wu H, Medina CA, Brose MS, Volpe P, Nussen-Lee S, Haupt HM, Martin AM, Herlyn M, Lessin SR, Weber BL.

J Med Genet. 2004 Apr;41(4):270-2.

18.

Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.

Handolias D, Salemi R, Murray W, Tan A, Liu W, Viros A, Dobrovic A, Kelly J, McArthur GA.

Pigment Cell Melanoma Res. 2010 Apr;23(2):210-5. doi: 10.1111/j.1755-148X.2010.00671.x. Epub 2010 Jan 20.

PMID:
20088873
19.

Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort.

Si L, Kong Y, Xu X, Flaherty KT, Sheng X, Cui C, Chi Z, Li S, Mao L, Guo J.

Eur J Cancer. 2012 Jan;48(1):94-100. doi: 10.1016/j.ejca.2011.06.056. Epub 2011 Jul 23.

PMID:
21788131
20.

Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site.

Platz A, Egyhazi S, Ringborg U, Hansson J.

Mol Oncol. 2008 Apr;1(4):395-405. doi: 10.1016/j.molonc.2007.12.003. Epub 2007 Dec 28.

Items per page

Supplemental Content

Write to the Help Desk